Build the file around the specific facility and proposed arrangement. Separate identity, regulatory status, inspection history, product provenance and operational capability.
Recommended evidence register:
| Area | Evidence to obtain or independently check |
|---|---|
| Identity | Contracting entity, producing facility, dispensing pharmacy and shipping subcontractors |
| Permissions | Relevant licences, registrations and scope |
| Inspection history | FDA and state findings, responses, corrective actions and subsequent status |
| Product sourcing | Authorized distribution evidence or applicable ingredient documentation |
| Quality | Release controls, complaint handling and relevant testing information |
| Handling | Storage, shipping validation and excursion disposition |
| Recall readiness | Product/lot identification and affected-patient notification process |
| Commercial resilience | Insurance, financial information, deposits and transition obligations |
FDA’s outsourcing register provides registration and selected inspection/action information. FDA also maintains a separate compounding inspections, recalls and actions resource. (fda.gov)
A Form FDA 483 records inspection observations; it is not itself a final agency determination of a violation. Review the subsequent response and disposition rather than treating the form as either an automatic ban or an irrelevant historical document. (fda.gov)
FDA explicitly states that outsourcing registration does not establish CGMP compliance or satisfaction of every 503B condition. (fda.gov)
Explore the table row by row
A working view of the research
Identity
- Evidence to obtain or independently check
- Contracting entity, producing facility, dispensing pharmacy and shipping subcontractors
Sources cited on this page
- fda.gov · Source 1 ↗https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities?utm_source=openai
- fda.gov · Source 2 ↗https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/inspection-references/fda-form-483-frequently-asked-questions?trk=article-ssr-frontend-pulse_little-text-block&utm_source=openai
- fda.gov · Source 3 ↗https://www.fda.gov/drugs/human-drug-compounding/questions-and-answers-outsourcing-facility-registration?utm_source=openai